Chapter 12 Renal Disease in Cryoglobulinemic Vasculitis

Handbook of Systemic Autoimmune Diseases

Volumn 7, Issue , 2007, Pages 215-239

  Bridoux, Frank ^a,b   Sirac, Christophe ^b   Jaccard, Arnaud ^c   Ayache, Ramzi Abou ^a   Goujon, Jean Michel ^a   Cogné, Michel ^b   Touchard, Guy ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b CNRS   (France)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649669575     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(07)07012-2     Document Type: Review

References (117)

1. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327 (1992) 1490-1495
2. Alric L., Plaisier E., Thebault S., et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am. J. Kidney Dis. 43 (2004) 617-623
3. Barton J.C., Herrera G.A., Galla J.H., Bertoli L.F., Work J., and Koopman W.J. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am. J. Med. 82 (1987) 624-629
4. Basse G., Ribes D., Kamar N., et al. Rituximab therapy mixed cryoglobulinemia in seven renal transplant patients. Transplant. Proc. 38 (2006) 2308-2310
5. Beaume A., Brizard A., Dreyfus B., and Preud'homme J.L. High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. Blood 84 (1994) 1216-1219
6. Bengtsson U., Larsson O., Lindstedt G., and Svalander C. Monoclonal IgG cryoglobulinemia with secondary development of glomerulonephritis and nephrotic syndrome. Q. J. Med. 44 (1975) 491-503
7. Bridoux F., Hugue V., Coldefy O., et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int. 62 (2002) 1764-1775
8. Brouet J.C., Clauvel J.P., Danon F., Klein M., and Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am. J. Med. 57 (1974) 775-788
9. Bruchfeld A., Lindahl K., Stahle L., Soderberg M., and Schvarcz R. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol. Dial. Transplant. 18 (2003) 1573-1580
10. Bryce A.H., Dispenzieri A., Kyle R.A., et al. Response to rituximab in patients with type II cryoglobulinemia. Clin. Lymphoma Myeloma 7 (2006) 140-144
11. Bryce A.H., Kyle R.A., Dispenzieri A., and Gertz M.A. Natural history and therapy of 66 patients with mixed cryoglobulinemia. Am. J. Hematol. 81 (2006) 511-518
12. Cacoub P., Lidove O., Maisonobe T., et al. Interferon alfa and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 46 (2002) 3317-3326
13. Cacoub P., Renou C., Kerr G., et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum. 44 (2001) 2118-2124
14. Cacoub P., Saadoun D., Limal N., Sene D., Lidove O., and Piette C. Pegylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 52 (2005) 911-915
15. Campise M., and Tarantino A. Glomerulonephritis in mixed cryoglobulinemia: what treatment?. Nephrol. Dial. Transplant. 14 (1999) 281-283
16. Carloss H.W., and Tavassoli M. Acute renal failure from precipitation of cryoglobulins in a cool operating room. J. Am. Med. Assoc. 244 (1980) 1472-1473
17. Casato M., Agnello V., Pucillo L.P., et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90 (1997) 3865-3873
18. Casato M., Pucillo L.P., Leoni M., et al. Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. Am. J. Med. 99 (1995) 386-391
19. Chantry D., Winearls C.G., Maini R.N., and Feldmann M. Mechanism of immune complex-mediated damage: induction of interleukin 1 by immune complexes and synergy with interferon-gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 19 (1989) 189-192
20. Cheng J.T., Anderson H.L., Markowitz G.S., Appel G.B., Pogue V.A., and D'Agati V.D. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J. Am. Soc. Nephrol. 10 (1999) 1566-1574
21. Cordonnier D., Martin H., Groslambert P., et al. Mixed IgG-IgM cryoglobulinemia with glomerulonephritis. Immunochemical, fluorescent and ultrastructural study of kidney and in vitro cryoprecipitate. Am. J. Med. 59 (1975) 867-872
22. Cordonnier D., Vialtel P., Renversez J.C., et al. Renal diseases in 18 patients with mixed type II IgM-IgG cryoglobulinemia: monoclonal lymphoid infiltration (2 cases) and membranoproliferative glomerulonephritis (14 cases). Adv. Nephrol. Necker Hosp. 12 (1983) 177-204
23. Curry M.P., Golden-Mason L., Doherty D.G., et al. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J. Hepatol. 38 (2003) 642-650
24. D'Amico G. Is type II mixed cryoglobulinemia an essential part of hepatitis C (HCV)-associated glomerulonephritis?. Nephrol. Dial. Transplant. 10 (1995) 1279-1282
25. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 54 (1998) 650-671
26. D'Amico G. Monoclonal cryoglobulinemia kidney. In: Touchard G., et al. (Ed). Monoclonal Gammopathies and the Kidney (2003), Kluwer Academic Publishers, Dordrecht 145-151
27. Dammaco F., Sansonno D., Han J.H., et al. Natural interferon-alfa versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 84 (1994) 3336-3343
28. De Vita S., Sacco C., Sansonno D., et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90 (1997) 776-782
29. Dussol B., Moal V., Daniel L., Pain C., and Berland Y. Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis. Nephrol. Dial. Transplant. 16 (2001) 156-159
30. Evans T.W., Nicholls A.J., Shortland J.R., et al. Acute renal failure in essential mixed cryoglobulinemia: precipitation and reversal by plasma exchange. Clin. Nephrol. 21 (1984) 287-293
31. Feldmann G., Nischalke H.D., Nattermann J., et al. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin. Cancer Res. 12 (2006) 4491-4498
32. Ferri C., Marzo E., Longombardo G., et al. Interferon-alfa in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 81 (1993) 1132-1136
33. Fornasieri A., Armelloni S., Bernasconi P., et al. High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis?. Am. J. Kidney Dis. 27 (1996) 476-483
34. Fornasieri A., and D'Amico G. Type II mixed cryoglobulinemia, hepatitis C virus infection, and glomerulonephritis. Nephrol. Dial. Transplant. 11 Suppl. 4 (1996) 25-30
35. Fornasieri A., Li M., Armelloni S., et al. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab. Invest. 69 (1993) 531-540
36. Fornasieri A., Tazzari S., Li M., et al. Electron microscopy study of genesis and dynamics of immunodeposition in IgMκ-IgG cryoglobulin-induced glomerulonephritis in mice. Am. J. Kidney Dis. 31 (1998) 435-442
37. Galea H.R., Bridoux F., Aldigier J.C., et al. Molecular study of an IgG1κ cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukemia. Clin. Exp. Immunol. 129 (2002) 113-118
38. Garin E.H., Fennell R.S., Shulman S.T., Iravani A., and Richard G.A. Clinical significance of the presence of cryoglobulins in patients with glomerulopathies not associated with systemic diseases. Clin. Nephrol. 13 (1980) 5-11
39. Gesualdo L., Grandaliano G., Ranieri E., et al. Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. Kidney Int. 51 (1997) 155-163
40. Gilboa N., Durante D., Guggenheim S., et al. Immune deposit nephritis and single component cryoglobulinemia associated with chronic lymphocytic leukemia. Nephron 24 (1979) 223-231
41. Grcevska L., Polenakovik M., and Polenakovik B. Renal involvement in essential monoclonal (type 1) IgG cryoglobulinemia. Clin. Nephrol. 50 (1998) 200-202
42. Haeney M.R. Erroneous values for the total white cell count and ESR in patients with cryoglobulinemia. J. Clin. Pathol. 28 (1976) 894-897
43. Hent R., Bergkamp F.J., Weening J.J., and van Dorp W. Delayed onset of membranoproliferative glomerulonephritis in a patient with type I cryoglobulinemia. Nephrol. Dial. Transplant. 12 (1997) 2155-2158
44. Herzenberg A.M., Telford J.J., De Luca L.G., Holden J.K., and Magil A.B. Thrombotic microangiopathy associated with cryoglobulin membranoproliferative glomerulonephritis and hepatitis C. Am. J. Kidney Dis. 31 (1998) 521-526
45. Hiesse C., Bastuji-Garin S., Santelli G., et al. Recurrent essential mixed cryoglobulinemia in renal allografts. Report of two cases and review of the literature. Am. J. Nephrol. 9 (1989) 150-154
46. Itoh J., Nose M., Takahashi S., et al. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Am. J. Pathol. 143 (1993) 1436-1443
47. Ivanovski M., Silvestri F., Pozzato G., et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91 (1998) 2433-2442
48. Johnson R.J., Gretch D.R., Couser W.G., et al. Hepatitis C virus-associated glomerulonephritis. Effect of α-interferon therapy. Kidney Int. 46 (1994) 1700-1704
49. Kallemuchikkal U., and Gorevic P.D. Evaluation of cryoglobulins. Arch. Pathol. Lab. Med. 123 (1999) 119-124
50. Kamar N., Ribes D., Izopet J., and Rostaing L. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive patients awaiting a kidney transplant. Transplantation 82 (2006) 853-856
51. Kamar N., Rostaing L., and Alric L. Treatment of hepatitis C-virus related glomerulonephritis. Kidney Int. 69 (2006) 436-439
52. Karras A., Noel L.H., Droz D., et al. Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3k cryoglobulin. Am. J. Kidney Dis. 40 (2002) 1091-1096
53. Kikuchi S., Pastore Y., Fossati-Jimack L., et al. A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia. J. Immunol. 169 (2002) 4644-4650
54. Kuroki A., Kuroda Y., Kikuchi S., et al. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor. Blood 99 (2002) 2922-2928
55. Lamprecht P., Lerin-Lozano C., Merz H., et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann. Rheum. Dis. 62 (2003) 1230-1233
56. Lemoine R., Berney T., Shibata T., et al. Induction of ''wire-loop'' lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 41 (1992) 65-72
57. Lenzi M., Frisoni M., Mantovani V., et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 91 (1998) 2062-2066
58. Libra M., Mangano K., Anzaldi M., et al. Analysis of interleukin (IL)-1beta, IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders. Oncol. Rep. 15 (2006) 1305-1308
59. Lunel F., Musset L., Cacoub P., et al. Cryoglobulinemia in liver diseases : role of hepatitis C virus and liver damage. Gastroenterology 106 (1994) 1291-1300
60. Madore F., Lazarus J.M., and Brady H.R. Therapeutic plasma exchange in renal diseases. J. Am. Soc. Nephrol. 7 (1996) 367-386
61. Mariette X. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factors. Ann. Rheum. Dis. 60 (2001) 1007-1011
62. Mazzaro C., Zorat F., Comar C., et al. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J. Rheumatol. 30 (2003) 1775-1781
63. Mazzaro C., Zorat F., Caizzi M., et al. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J. Hepatol. 42 (2005) 632-638
64. Meltzer M., Franklin E.C., Elias K., McCluskey R.J., and Cooper W. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am. J. Med. 40 (1966) 837-856
65. Misiani R., Bellavita P., Fenili D., et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Am. J. Med. 117 (1992) 573-577
66. Misiani R., Bellavita P., Fenili D., et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Engl. J. Med. 330 (1994) 751-756
67. Monti G., Galli M., Invernizzi F., et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinemias. Q. J. Med. 88 (1995) 115-126
68. Morales E., Alegre R., Herrero J.C., Morales J.M., Ortuno T., and Praga M. Hepatitis-C-virus-associated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV. Nephrol. Dial. Transplant. 12 (1997) 1980-1984
69. Morales J.M. Hepatitis C virus infection and renal diseases after renal transplantation. Transplant. Proc. 36 (2004) 760-762
70. Mougenot, B., Ronco, P. 1996. La biopsie rénale dans les dysprotéinémies et les dysglobulinémies. In: La biopsie rénale. Droz D, Lantz B, eds. Editions INSERM pp. 237-265.
71. Musset L., Duarte F., Gaillard O., et al. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins. Clin. Immunol. Immunopathol. 70 (1994) 166-170
72. Nehme-Schuster H., Korganow A.S., Pasquali J.L., and Martin T. Rituximab inefficiency during type I cryoglobulinaemia. Rheumatol. (Oxford) 44 (2005) 410-411
73. Odum J., D'Costa D., Freeth M., Taylor D., Smith N., and MacWhannell A. Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment. Nephrol. Dial. Transplant. 16 (2001) 403-406
74. Ogihara T., Saruta T., Saito I., et al. Finger print deposits of the kidney in pure monoclonal IgG kappa cryoglobulinemia. Clin. Nephrol. 12 (1979) 186-190
75. Okuda K., Yokosuka O., Otake Y., et al. Cryoglobulinaemia among maintenance haemodialysis patients and its relation to hepatitis C infection. J. Gastroenterol. Hepatol. 13 (1998) 248-252
76. Panka D.J., Salant D.J., Jacobson B.A., Minto A.W., and Marshak-Rothstein A. The effect of VH residues 6 and 23 on IgG3 cryoprecipitation and glomerular deposition. Eur. J. Immunol. 25 (1995) 279-284
77. Papo T., Musset L., Bardin T., et al. Cryocrystalglobulinaemia as a cause of systemic vasculopathy and widespread erosive arthropathy. Arthritis Rheum. 39 (1996) 335-340
78. Pham H.P., Feray C., Samuel D., et al. Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver recipients. Kidney Int. 54 (1998) 1311-1319
79. Pol S., Vallet-Pichard A., Fontaine H., and Lebray P. HCV infection and hemodialysis. Semin. Nephrol. 22 (2002) 331-339
80. Ponticelli C., Imbasciati E., Tarantino A., and Pietrogrande M. Acute anuric glomerulonephritis in monoclonal cryoglobulinemia. Br. Med. J. 1 (1977) 948
81. Preud'homme J.L., Aucouturier P., Touchard G., et al. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int. 46 (1994) 965-972
82. Provot F., Bridoux F., Vanhille P., et al. Spectrum of glomerular disease in type I cryoglobulinemia. J. Am. Soc. Nephrol. 11 (2000) 95A
83. Quartuccio L., Soardo G., Romano G., et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatol. (Oxford) 45 (2006) 842-846
84. Racanelli V., Sansonno D., Piccoli C., D'Amore F.P., Tucci F.A., and Dammacco F. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J. Immunol. 67 (2001) 21-29
85. Realdon S., Pontisso P., Adami F., et al. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. J. Hepatol. 34 (2001) 723-729
86. Rengers J.U., Touchard G., Decourt C., Deret S., Hartmut M., and Cogné M. Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia. Blood 65 (2000) 3467-3472
87. Rocatello D., Baldovino S., Rossi D., et al. Long-term effects of an anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol. Dial. Transplant. 19 (2004) 3054-3061
88. Roccatello D., Isidoro C., Mazzucco G., et al. Role of monocytes in cryoglobulinemia-associated nephritis. Kidney Int. 43 (1993) 1150-1155
89. Roccatello D., Morsica G., Picciotto G., et al. Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C (HCV) virus infection. Clin. Exp. Immunol. 110 (1997) 9-14
90. Rollino C., Dieny A., Le Marc'hadour F., Renversez J.C., Pinel N., and Cordonnier D. Double monoclonal cryoglobulinemia, glomerulonephritis and lymphoma. Nephron 62 (1992) 459-464
91. Rossi P., Bertani T., Baio P., et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int. 63 (2003) 2236-2241
92. Russo G.E., Caramiello M.S., Vitaliano E., et al. Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment. Transfus. Sci. 17 (1996) 499-503
93. Saadoun D., Aaron L., Resche-Rigon M., Pialoux G., Piette J.C., and Cacoub P. GERMIVIC Study Group. Cryoglobulinaemia vasculitis in patients co-infected with HIV and hepatitis C virus. AIDS 20 (2006) 871-877
94. Saadoun D., Boyer O., Trebeden-Negre H., et al. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis. J. Hepatol. 41 (2004) 1031-1037
95. Saadoun D., Resche-Rigon M., Thibault V., Piette J.C., and Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis. Arthritis Rheum. 54 (2006) 3696-3706
96. Sansonno D., and Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect. Dis. 5 (2005) 227-236
97. Sansonno D., De Re V., Lautella G., Tucci F.A., Boiocchi M., and Dammaco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alfa with an anti-CD20. Blood 101 (2003) 3818-3826
98. Sens Y.A., Malafronte P., Souza J.F., et al. Cryoglobulinemia in kidney transplant recipients. Transplant. Proc. 37 (2005) 4273-4275
99. Siami G.A., Siami F.S., Ferguson P., Stone W.J., and Zborowski M. Cryofiltration apheresis for treatment of cryoglobulinemia associated with hepatitis C. ASAIO J. 41 (1995) M315-M318
100. Stefanutti C., Di Giacomo S., Mareri M., et al. Immunoadsorption apheresis (Selesorb) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia. Transfus. Apher. Sci. 28 (2003) 207-214
101. Su C.C., Chen H.H., Yeh J.C., Chen S.C., Liu C.C., and Tzen C.Y. Ultrastructural 'fingerprint' in cyoprecipitates and glomerular deposits: a clinicopathologic analysis of fingerprint deposits. Nephron 90 (2002) 37-42
102. Taneda S., Segerer S., Hudkins K.L., et al. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am. J. Pathol. 159 (2001) 2355-2369
103. Tarantino A., De Vecchi A., Montagnino G., et al. Renal disease in essential mixed cryoglobulinemia. Long-term follow-up of 44 patients. Q. J. Med. 50 (1981) 1-30
104. Tarantino A., Campise M., Banfi G., et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int. 47 (1995) 618-623
105. Tarantino A., Moroni G., Banfi G., Manzoni C., Segagni S., and Ponticelli C. Renal replacement therapy in cryoglobulinaemic nephritis. Nephrol. Dial. Transplant. 9 (1994) 1426-1430
106. Tissot J.D., Schifferli J.A., Hochstrasser D.F., et al. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J. Immunol. Methods 173 (1994) 63-75
107. Tomiyoshi Y., Sakemi T., Yoshikawa Y., Shimokama T., and Watanabe T. Fibrillar crystal structure in essential monoclonal IgM kappa cryoglobulinemia. Clin. Nephrol. 49 (1998) 325-327
108. Touchard G. Ultrastructural pattern and classification of renal monoclonal immunoglobulin deposits. In: Touchard G., et al. (Ed). Monoclonal Gammopathies and the Kidney (2003), Kluwer Academic Publishers, Dordrecht 95-117
109. Touchard G., Bauwens M., Goujon J.M., Aucouturier P., Patte D., and Preud'homme J.L. Glomerulonephritis with organized microtubular monoclonal immunoglobulin deposits. Adv. Nephrol. Necker Hosp. 23 (1994) 149-175
110. Trejo O., Ramos-Casals M., Garcia-Carrasco, et al. Cryoglobulinemia. Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine 80 (2001) 252-262
111. Trendelenburg M., Fossati-Jimack L., Cortes-Hernandez H., et al. The role of complement in cryoglobulin-induced immune complex glomerulonephritis. J. Immunol. 175 (2005) 6909-6914
112. Verroust P., Mery J.P., Morel-Maroger L., et al. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM. Adv. Nephrol. Necker Hosp. 1 (1971) 161-194
113. Weiner S.M., Thiel J., Berg T., et al. Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV-infected renal allograft recipients. Clin. Transplant. 18 (2004) 7-13
114. Zaja F., De Vita S., Mazzaro C., et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101 (2003) 3827-3834
115. Zignego A.L., Ferri C., Gianelli F., et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann. Intern. Med. 137 (2002) 571-580
116. Zignego A.L., Macchia D., Monti M., et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 15 (1992) 382-386
117. Zuckerman E., Keren D., Slobodin G., et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon alfa. J. Rheumatol. 27 (2000) 2172-2178